Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfuxin Liquid for gastric ulcer wound healing quality after ESD
ChiCTR1900026682Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of kangfuxin in gastric ulcer (2 arms), sponsored by Renji Hospital. Primary endpoints: Pathological index and Inflammatory factor. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
kangfuxin
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on ChiCTR1900026682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026682.